Skip to main content
. 2016 Jun;6(3):221–233. doi: 10.21037/cdt.2016.03.01

Table 2. B-type natriuretic peptide levels in patients with and without renal function improvement during follow up.

BNP levels All patients Improvement in renal function No improvement in renal function P value
Overall cohort [n=127] [n=42] [n=73]
   BNP pre-intervention (pg/mL) 97 [35, 254] 103 [48, 366] 95 [31, 193] 0.10
   BNP 1 day post-intervention (pg/mL) 63 [24, 179]* 87 [35, 217]* 55 [22, 144] 0.15
   %BNP decrease −31 [−57, 6] −35 [−55, −1] −29 [−52, 15] 0.33
   BNP 6 months post-intervention (pg/mL) 75 [31, 190] 114 [41, 181] 60 [23, 103] 0.47
Patients with baseline eGFR <60 mL/min/1.73 m2 [n=56] [n=27] [n=22]
   BNP pre-intervention (pg/mL) 164 [65, 352] 168 [60, 399] 182 [93, 362] 0.82
   BNP 1 day post-intervention (pg/mL) 118 [50, 238] 124 [48, 235] 139 [59, 411] 0.47
   %BNP decrease −26 [−59,10] −30 [−60, 0] 1 [−50, 23] 0.12
   BNP 6 months post-intervention (pg/mL) 125 [62, 194] 125 [46, 181] 169 [87, 361] 0.18

*, P<0.001 compared with BNP pre-intervention; , P<0.05 compared with BNP pre-intervention. BNP, B-type natriuretic peptide; BP, blood pressure; LVEF, left ventricular ejection fraction; RAS, renal artery stenosis. Data are expressed as median [25th and 75th percentiles), or number [percentage) of patients.